Mycosis fungoides after solid-organ transplantation: Report of 2 new cases

American Journal of Dermatopathology

Volumn 30, Issue 2, 2008, Pages 150-155

  Rodríguez Gil, Yolanda ^a   Palencia, Sara Isabel ^a   López Ríos, Fernando ^a   Ortiz, Pablo L ^a   Rodríguez Peralto, Jose L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cutaneous lymphoma; Epstein Barr virus; Graft recipients; Immunosuppressive treatment; Lymphoma; Mycosis fungoides; Posttransplant lymphoproliferative disorder; T cell lymphoma; Transplantation

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; CASE REPORT; CLINICAL FEATURE; FEMALE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYCOSIS FUNGOIDES; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; ORGAN TRANSPLANTATION; PARANEOPLASTIC SYNDROMES; PUVA THERAPY; RISK ASSESSMENT; SKIN NEOPLASMS; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 41149145622     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318164cf6e     Document Type: Article

References (58)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003;348:1681-1691.
2. Harwood C, Proby C, McGregor J, et al. Clinicopathological features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol. 2006;54:290-300.
3. Kanitakis J, Euvard S, Claudy A. Skin cancers in organ transplant recipients. J Am Acad Dermatol. 2006;54:1115.
4. Webb MC, Compton F, Andrews PA, et al. Skin tumors posttransplantation: a retrospective analysis of 28 years experience at a single centre. Transplant Proc. 1997;29:828-830.
5. Hiesse C, Rieu P, Kriaa F, et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during 25-years period. Transplant Proc. 1997;29:831-833.
6. Lutzner MA. Skin cancer in immunosuppressed organ transplant recipients. J Am Acad Dermatol. 1984;11:891-893.
7. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990; 323:1767-1769.
8. Ward HA, Russo GG, McBurney E, et al. Posttransplant primary cutaneous T-cell lymphoma. J Am Acad Dermatol. 2001;44:675-680.
9. Harris NL, Swedlow SH, Frizzera G, et al. Post-transplant Lymphoproliferative Disorders. World Health Organization Classification of Tumors. Tumors of the Hematopoietic and Lymphoid Tissues. Lyon, PA: IARC Press; 2001: 264-270.
10. Lassoued K, Ghez D. Physiopathology of B cell lymphoproliferations. In: Touchard G, Aucouturier P, Hermine O, et al, eds. Monoclonal Gammapathies and the Kidney. London: Kluver Academic Publishers; 2003:15-25.
11. Nalesnik MA. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis. 2001;3:88-96.
12. Penn I, Brunson ME. Cancers after cyclosporine therapy. Transplant Proc. 1988;20(Suppl):885-892.
13. McGregor JM, Yu CCW, Lu QL, et al. Posttransplant cutaneous lymphoma. J Am Acad Dermatol. 1993;29:549-554.
14. Dreno B. Skin cancers after transplantation. Nephrol Dial Transplant. 2003;18:1052-1058.
15. Cerroni L, Gatter K, Kerl H. Cutaneous T-cell lymphomas. In: Cerroni L, Gatter K, Kerl H, eds. An Illustrated Guide to Skin Lymphoma. Massachussets, PA: Blackwell Publishing; 2004:30-31.
16. Euvrard S, Noble CP, Kanitakis J, et al. Brief report: successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous-cell carcinomas. N Engl J Med. 1992;31:1924-1926.
17. Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol. 2006;54:668-75.
18. Kaplan MA, Jacobson JO, Ferry JA, et al. T-cell lymphoma of the vulva in a renal allograft recipient with associated hemophagocytosis. Am J Surg Pathol. 1993;17:842-9.
19. Ichikawa Y, Iida M, Ebisui C, et al. A case study of adult T-cell lymphoma in a kidney transplant patient. Transplant Proc. 2000;32:1982-3.
20. Lye WC. Successful treatment of Epstein-Barr virus-associated T-cell cutaneous lymphoma in a renal allograft recipient: case report and review of the literature. Transplant Proc. 2000;32:1988-9.
21. McMullan DM, Radovaneevic B, Jackow CM, et al. Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J. 2001;28: 203-7.
22. Cooper SM, Turner GD, Hollowood K, et al. Primary cutaneous large cell CD30+ lymphoma in a renal transplant recipient. Br J Dermatol. 2003; 149:426-8.
23. Thein M, Ravat F, Orchard G, et al. Syringotropic cutaneous T-cell lymphoma: an immunophenotypic and genotypic study of five cases. Br J Dermatol. 2004;151:216-26.
24. Salama S. Primary "cutaneous" T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review. Am J Dermatopathol. 2005;27:217-23.
25. Nisi MC, D'Amuri A, Lalinga AV, et al. Posttransplant primary cutaneous CD30 (Ki-1)-positive anaplastic large T-cell lymphoma. A case report. Br J Dermatol. 2005;152:1068-70.
26. Bregman SG, Yeaney GA, Greig BW, et al. Subcutaneous panniculitic T-cell lymphoma in a cardiac allograft recipient. J Cutan Pathol. 2005;32: 366-70.
27. Katugampola RP, Finlay AY, Harper JI, et al. Primary cutaneous CD30+ T-cell lymphoproliferative disorder following cardiac transplantation in a 15-year-old boy with Netherton's syndrome. Br J Dermatol. 2005;153:1041-6.
28. Lucioni M, Ippoliti G, Campana C, et al. EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant. 2004;4:1915-20.
29. Coyne JD, Banerjee SS, Bromley M, et al. Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology. 2004;44:387-93.
30. Kim HK, Jin SY, Lee NS, et al. Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma. Arch Pathol Lab Med. 2004;128:e96-9.
31. Seckin D, Demirhan B, Karakayali H, et al. Immunohistochemical expression of p53, Bcl-2, Bax, and Fas proteins in squamous cell carcinomas from immunosuppressed renal transplant recipients and immunocompetent individuals. Transplant Proc. 2002;34:2139-40.
32. Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001;91:869-75.
33. Raftery MJ, Tidman MJ, Koffman G, et al. Posttransplantation T cell lymphoma of the skin. Transplantation. 1988;46:475-7.
34. Tomson CR, Graham S, Hutchinson RM, et al. Sezary cell lymphoma following cyclosporin immunosuppression for renal transplantation. Nephrol Dial Transplant. 1991;6:896-8.
35. Pascual J, Torrelo A, Teruel JL, et al. Cutaneous T cell lymphomas after renal transplantation. Transplantation. 1992;53:1143-5.
36. Schunemann R, Winfield, Ahmed I. Cutaneous T-cell post-transplant lymphoproliferative disorder clinically masquerading as cellulites and presenting with subcutaneous lesions ASDP meeting 1998. Am J Cutan Pathol. 1998;25:512
37. Lok C, Viseux V, Denoeux JP, et al. Post-transplant cutaneous T-cell lymphomas. Crit Rev Oncol Hematol. 2005;56:137-45.
38. Burg G, Kempf W, Cozzio A, et al. HO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32:647-674.
39. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520-529.
40. Touraine JL, Traeger J. Malignant lymphoproliferative disorders of viral origin in transplant patients undergoing immunosuppressive therapy. Cancer Detect Prev Suppl. 1987;1:159-164.
41. Cleary ML, Sklar J. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet. 1984;2:489-493.
42. Randhawa PS, Yousem SA, Paradis IL, et al. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol. 1989;92:177-185.
43. Polson RJ, Neuberger J, Forman D, et al. De novo malignancies after liver transplantation. Transplant Proc. 1988;20:94-97.
44. Van Gorp J, Doornewaard H, Verdonck LF, et al. Posttransplant T cell lymphoma. Report of three cases and a review of the literature. Cancer. 1994;73:3064-3072.
45. FDA Alert (03/2005). Information for Healthcare Professionals. Tacrolimus (marketed as Protopic).
46. Starzl TE, Penn I, Putnam CW, et al. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev. 1971;7:112-145.
47. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984;1:583587.
48. Leblond V, Sutton L, Dorent R, et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol. 1995;13:961.
49. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996;87:1474
50. Yasunaga C, Kasai T, Nishihara G, et al. Early development of epstein-barr virus-associated t-cell lymphoma after a living-related renal transplantation. Transplantation. 1998;65:1642-1644.
51. Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. J Clin Invest. 1995;95: 547-554.
52. Bazarbachi A, Soriano V, Pawson R, et al. Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol. 1997;98:927-933.
53. Fink-Puches R, Zenahlik P, Back B, et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood. 2002;99:800-805.
54. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood. 1997;90:354-371.
55. Thein M, Ravat F, Orchard G, et al. Syringotropic cutaneous T-cell lymphoma: an immunophenotypic and genotypic study of five cases. Br J Dermatol. 2004;151:216-226.
56. Defossez-Tribout C, Carmi E, Lok C, et al. Cutaneous T-cell lymphoma following renal transplantation. Ann Dermatol Venereol. 2003;130:47-49.
57. Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Hum Pathol. 1996;27:125-132.
58. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514-1516.